about
Clinical Implications of Antiviral Resistance in InfluenzaAntivirals for influenza: a summary of a systematic review and meta-analysis of observational studiesWhat is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong KongAdjunctive therapies and immunomodulating agents for severe influenza.Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts.Statin treatment and mortality: propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations.The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in ChinaImpact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.Influenza and its treatment during pregnancy: A review.Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea.Co-infection of Influenza B and Streptococci causing severe pneumonia and septic shock in healthy womenClinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Impact of the 2009/2010 influenza A (H1N1) pandemic on trends in influenza hospitalization, diagnostic testing, and treatment.Peramivir for the treatment of influenza.Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality.Influence of time to diagnosis of severe influenza on antibiotic use, length of stay, isolation precautions, and mortality: a retrospective studyReducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department.Volatile emanations from in vitro airway cells infected with human rhinovirus.Maternal and fetal recovery after severe respiratory failure due to influenza: a case report.Predictors of viral pneumonia in patients with community-acquired pneumonia.Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza seasonImmunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.Acute respiratory distress syndrome caused by influenza B virus infection in a patient with diffuse large B-cell lymphoma.Seasonal influenza A virus in feces of hospitalized adults.Morbidity, Mortality, and Seasonality of Influenza Hospitalizations in Egypt, November 2007-November 2014Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersPredictors of influenza among older adults in the emergency department.A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients.Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children.
P2860
Q26782746-3E435A04-731A-4F49-904A-72D0B9525D9EQ26852067-1339C53D-B7F2-41DA-80AD-A0E7A65740B5Q26852219-0AC51820-3100-4B6B-9162-9628520DC7EFQ28730856-DF102E60-1D21-4F12-A44F-7DD2024405DCQ30355446-1CA9CA73-3E98-4AD1-B116-0867EFA2EE0CQ30357688-92C204DF-B59A-4A7D-8644-BCFDDB7258D6Q30358632-816285BE-315A-48F4-9BD6-1759F36DC1C2Q30368552-FA5277C3-5260-48EB-ACC3-A3348B4CFCA1Q30375212-F0C105E2-11BD-4C2E-A059-4B0C3FDEB481Q30377116-A744D567-20B0-4171-8FEE-E600219DA398Q30381799-0DB0BAC0-A531-429A-B4D9-C425F82A67F9Q30384118-14726ADB-562B-4CC7-A995-725D1AF44E65Q30388177-C2C515A1-BDE7-45BE-8A3C-0FCAB31BFDB4Q30394593-D0005530-4C97-4B29-BD3D-8888EBCCAA03Q30395322-3B4B8568-BC4C-4394-80BA-68A02B76DAB3Q30398779-070D6755-36E2-4E8D-9F13-A94DC8130A9CQ30399530-1E2CDC97-9223-4FE8-BD55-D502FD6EC6F9Q30400342-EC8C27CA-FD07-4473-82A1-93DE9BF1054EQ30404888-493653FA-FCAB-457D-905F-686807D34065Q30409023-BF85B7A9-E080-4D2D-BA2C-7C9113AC54FDQ30409501-911807D5-85ED-4F3E-8865-4821EBC26720Q30413154-0FDF809F-B763-4FDC-9EAE-70E643658ECEQ30415719-65E4CD0C-0F02-4DB4-A0EC-DFE29E803073Q30419774-A0DAE2D7-A9D3-487E-B40D-FBF8A0769806Q30425347-CBECFB5A-3E3B-425C-8DB3-747E86629873Q33828481-0C74DC5B-5D98-4C04-B27E-5158CECD94CAQ33838098-36BDCF1F-90F4-497D-AB3C-755D4C84DE9BQ33940879-B6DB0D72-D337-4C90-8D18-7810B566061DQ34278211-EE3ABCC1-B040-49C1-B3AD-284ED1FB9131Q34588785-F3EA1C73-991D-4631-A616-0B8803D7C12AQ34756780-9F0EF617-8762-419D-9489-E8F1027D1A17Q34802199-8E556B1C-2EA2-4449-B6F6-3D2DC38A377DQ34862926-1DDD82C4-3881-4D90-9478-1BA653AEC53FQ35512344-64D6FD29-7332-4438-92BD-EFE5DD3F53F2Q35847198-1966BC49-2CB6-4927-84E1-D31F67DB3DDAQ36126614-41F4DD70-FEE2-42E1-BE09-4C63624BB085Q36172477-AEBCB714-809E-4F49-9B3B-A78C9387781EQ36177516-B077B0B1-ACF6-4E4A-BED2-8B1172735D7BQ36376234-720E70D1-4D9F-47D7-8E05-B013B31CE600Q37546216-B9F39D45-A22F-44AE-9CEF-035916C84B0A
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Outcomes of adults hospitalised with severe influenza.
@en
Outcomes of adults hospitalised with severe influenza.
@nl
type
label
Outcomes of adults hospitalised with severe influenza.
@en
Outcomes of adults hospitalised with severe influenza.
@nl
prefLabel
Outcomes of adults hospitalised with severe influenza.
@en
Outcomes of adults hospitalised with severe influenza.
@nl
P2093
P50
P356
P1433
P1476
Outcomes of adults hospitalised with severe influenza
@en
P2093
B C K Wong
C S Cockram
K L K Ngai
R Y K Wong
P304
P356
10.1136/THX.2009.130799
P407
P577
2010-06-01T00:00:00Z